Friday 6 November 2026 Export RMD’s income statement to Excel — free account

ResMed Inc.

RMD Healthcare Medical Instruments & Supplies

ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025.

Revenue: +5.93%
EPS: +23.1%
Free cash flow: −9.79%
Total debt: −38.9%

Quarter to September 2026, against a year earlier

238.80 1.71 −0.71%

Follow RMD

Alert me

Market cap: $33.7B
P/E: 21.7×
Fwd P/E: 19.6×
Dividend yield: 1.03%
F-score: 6/9
Altman Z: 10.00
Beneish M: −2.59
Dividend safety: 96/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

ResMed Inc. 8-K filed Aug 17, 2026

Period ended Aug 13, 2026 · Filed Aug 17, 2026 · accepted 4:30 PM ET · Document on sec.gov · Filing index

4.01 Change in the certifying accountant; 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits

Red flags

Auditor change Aug 17, 2026
ResMed Inc. reported a change of its independent auditor

8-K filed Aug 17, 2026 · The filing · sec.gov
Officer departure Aug 17, 2026
ResMed Inc. reported the departure of an officer or director

8-K filed Aug 17, 2026 · The filing · sec.gov

ResMed Inc. 8-K filed Aug 17, 2026

Red flags

Stockrow Weekly